Posted 2/22/2024, 11:21:23 PM
Nevro Beats Q4 Estimates with 2% Revenue Growth to $116M, Narrows Losses on Commercial Realignment
- Nevro's revenue rose 2% year-over-year to $116 million in Q4, beating analyst estimates
- Nevro narrowed its net loss to $7 million in Q4, also exceeding expectations
- Nevro attributed the improvements to strategic measures like its commercial realignment and acquisition of Vyrsa Technologies
- Nevro provided full-year 2024 revenue guidance of $435-445 million (2-5% growth) and adjusted EBITDA of -$8 to -$14 million
- Nevro appointed a new board member, Kirt Karros, as part of a cooperation agreement with activist investor Engaged Capital